Roche
Deals on record
1
Common Fundraising Type
Series B
NMD Pharma
Clinical-stage biotech • Small molecule therapies
NMD Pharma is a biotech company focused on developing small molecule therapies for neuromuscular diseases by targeting the skeletal muscle chloride ion channel (ClC-1).